117977-21-6: Rabeprazole Related Compound E

Rabeprazole Related Compound E (CAS No: 117977-21-6) or 2-[[4-(3-Methoxypropoxy)-3-methyl-pyridin-2-yl]methylthio]benzoimidazole, belongs to an antiulcer drug that class of proton pump inhibitors and used For the treatment of acid-reflux disorders.

Additional information on CAS 117977-21-6

Catalogue No.

VL970008

CAS No.

117977-21-6

Molecular Formula

C18H21N3O2S

Molecular Weight

343.44

Parent drug

Rabeprazole

IUPAC Name

2-[[4-(3-Methoxypropoxy)-3-methyl-pyridin-2-yl]methylthio]benzoimidazole

Synonyms

2-[[(4-Chloro-3-methyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole; Rabeprazole EP Impurity H (Lansoprazole EP Impurity F)

References

Pace, Fabio, et al. “A Review of Rabeprazole in the Treatment of Acid-Related Diseases.” Therapeutics and Clinical Risk Management, vol. 3, no. 3, Dove Medical Press, 2007, pp. 363–79, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386363/. ?

Status

In-stock

[rfq_list]

Login first to add product to RFQ List

Request a quote

117977-21-6: Rabeprazole Related Compound E

117977-21-6: Rabeprazole Related Compound E
Catalogue No.

VL970008

CAS No.

117977-21-6

Molecular Formula

C18H21N3O2S

Molecular Weight

343.44

Parent drug

Rabeprazole

IUPAC Name

2-[[4-(3-Methoxypropoxy)-3-methyl-pyridin-2-yl]methylthio]benzoimidazole

Synonyms

2-[[(4-Chloro-3-methyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole; Rabeprazole EP Impurity H (Lansoprazole EP Impurity F)

References

Pace, Fabio, et al. “A Review of Rabeprazole in the Treatment of Acid-Related Diseases.” Therapeutics and Clinical Risk Management, vol. 3, no. 3, Dove Medical Press, 2007, pp. 363–79, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386363/. ?

Status

In-stock

ListName

Rabeprazole Related Compound E

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden